0001209191-23-048905.txt : 20230911 0001209191-23-048905.hdr.sgml : 20230911 20230911135212 ACCESSION NUMBER: 0001209191-23-048905 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230907 FILED AS OF DATE: 20230911 DATE AS OF CHANGE: 20230911 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Huizenga Theodore Alan CENTRAL INDEX KEY: 0001603347 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36276 FILM NUMBER: 231247446 MAIL ADDRESS: STREET 1: C/O ULTRAGENYX PHARMACEUTICAL INC. STREET 2: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ultragenyx Pharmaceutical Inc. CENTRAL INDEX KEY: 0001515673 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 272546083 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 415-483-8800 MAIL ADDRESS: STREET 1: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-09-07 0 0001515673 Ultragenyx Pharmaceutical Inc. RARE 0001603347 Huizenga Theodore Alan C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO CA 94949 0 1 0 0 SVP, Chief Accounting Officer 0 Common Stock 2023-09-07 4 M 0 2000 21.00 A 25777 D Common Stock 2023-09-07 4 S 0 2000 41.00 D 23777 D Common Stock 2023-09-07 4 S 0 163 38.34 D 23614 D Stock Option (Right to Buy) 21.00 2023-09-07 4 M 0 2000 0.00 D 2024-01-29 Common Stock 2000 3000 D The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023. Includes previously reported shares of common stock underlying restricted stock units granted to the Reporting Person, which are subject to certain vesting conditions. 1/4th of the option vested one year from January 29, 2014 and then 1/48th of the option vested monthly thereafter. /s/ Karah Parschauer, attorney-in-fact 2023-09-11